ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

IMMX Immix Biopharma Inc

2.45
0.10 (4.26%)
2024年5月7日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Immix Biopharma Inc IMMX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.10 4.26% 2.45 08:38:06
始値 安値 高値 終値 前日終値
2.35 2.26 2.50 2.33 2.35
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/2/0807:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0623:09EDGAR2Form 8-K - Current report
2024/2/0606:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0606:37EDGAR2Form 8-K - Current report
2023/12/1308:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2900:48IHNWImmix Biopharma Announces FDA Approval of IND Application..
2023/11/1009:57EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2023/9/2605:15EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/9/1908:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1607:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3105:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/8/2405:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2305:05EDGAR2Form 8-K - Current report
2023/8/1505:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1505:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1505:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1505:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1205:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2521:42GLOBEImmix Biopharma Subsidiary Nexcella Announces NXC-201..
2023/7/1722:37GLOBEImmix Biopharma Reports 2nd Positive Interim Clinical Trial..
2023/7/1506:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1506:26EDGAR2Form 8-K - Current report
2023/7/1022:47GLOBEImmix Biopharma Subsidiary Nexcella Completes Initial..
2023/6/2622:49GLOBEImmix Biopharma Subsidiary Nexcella Completes Pre-IND..
2023/6/2222:53GLOBEImmix Biopharma Subsidiary Nexcella Appoints Edward J...
2023/6/2022:45GLOBEImmix Biopharma Subsidiary Nexcella Appoints Jeffrey H...
2023/6/1622:43GLOBEImmix Biopharma Subsidiary Nexcella Appoints Mary Sue..
2023/6/1420:30GLOBEImmix Biopharma Completes $5 Million At-The-Market Equity..
2023/6/1222:49GLOBEImmix Biopharma Subsidiary Nexcella Appoints Henry..
2023/5/2622:53GLOBEImmix Biopharma Subsidiary Nexcella Announces Commencement..
2023/5/2205:05GLOBENexcella Announces Positive NXC-201 Clinical Results at..
2023/5/2205:00GLOBEImmix Biopharma Announces Positive NXC-201 Clinical Results..

最近閲覧した銘柄

Delayed Upgrade Clock